DePuy Synthes drives Johnson & Johnson’ orthopedics and spine lines. Here are 10 numbers that illustrate how big the company is.
1. DePuy Synthes Companies generate around $10 billion in annual sales.
2. DePuy Synthes Companies has around 18,000 employees in 60 countries.
3. Worldwide, the DePuy Synthes’ products support around 1 million orthopedic procedures per year.
4. In a survey of 107 patients who underwent outpatient total joint replacement at four ASCs with DePuy Synthes products, 96.3 percent said they would choose outpatient joint replacement again.
5. Johnson & Johnson has 16 percent of the spine market, according to a report from The Spine Market Group.
6. Johnson & Johnson had around 21.8 percent of the orthopedics market share in 2017 and is expected to have 24.2 percent in 2024, according to Statista rankings.
7. In 2019, Johnson & Johnson reported worldwide orthopedic sales of $8.8 billion.
8. Spine and other sales hit $3.2 billion last year.
9. Johnson & Johnson reported both hip and knee sales hit $1.4 billion in 2019.
10. Last year, DePuy Synthes and Johnson & Johnson Medical Device Companies launched, released or received FDA clearance for at least seven products.
More articles on spine devices:
Drs. Scott Blumenthal, Richard Guyer & more: 6 Texas Back spine surgeons reflect on 20 years of artificial disc replacement
Spinal fusion market to hit $8.6B by 2025, driven by surgical innovation, aging population
4 spine, neurosurgeons on the move in January
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
